Open Access · CC BY 4.0
Integrating Biomarker‐Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors
iLABMED · 2026-06 · 4 (2) · 130-131
DOI: 10.1002/ila2.70056 ↗Kurz gefasst
Fachartikel in der Zeitschrift iLABMED, online erschienen am 30.05.2026. Verfasst von Xudong Song und 2 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, X., Dai, J., & Tao, G. (2026). Integrating Biomarker‐Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors. iLABMED, 4(2), 130-131. https://doi.org/10.1002/ila2.70056
Vancouver
Song X, Dai J, Tao G. Integrating Biomarker‐Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors. iLABMED. 2026;4(2):130-131. doi:10.1002/ila2.70056
BibTeX
@article{Song2026,
author = {Song, Xudong and Dai, Jingjing and Tao, Guoquan},
title = {Integrating Biomarker‐Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors},
journal = {iLABMED},
year = {2026},
volume = {4},
number = {2},
pages = {130--131},
doi = {10.1002/ila2.70056}
}
EUVIMED